Table 1.
Data source | Independent variable | Additional covariatea | OR (95% CI)b | P-value |
---|---|---|---|---|
Derivation setc | LV Mass measured | None | 2.1 (2.0–2.3) | <2 × 10−16 |
LV Mass PRS | None | 2.0 (1.9–2.1) | <2 × 10−16 | |
LV Mass PRS | LV Mass measured | 1.1 (0.99–1.31) | 0.06 | |
LV Mass PRS | Height | 2.0 (1.9–2.2) | <2 × 10−16 | |
LV Mass PRS | BMI | 1.9 (1.8–2.1) | <2 × 10−16 | |
LV Mass permuted PRS | None | 0.99 (0.94–1.04) | 0.66 | |
Validation set 1: BioVUd | LV Mass PRS | None | 1.08 (1.02–1.13) | 0.002 |
Validation set 2: eMERGEe | LV Mass PRS | None | 1.10 (1.06–1.14) | 4.1 × 10−7 |
aAdditional covariate added to the logistic regression model.
bAnalyses are based on a logistic regression model using the PheWAS phenotype cardiomegaly as the dependent variable and specified independent variable. All independent variables were set to have a standard deviation of 1. All models were additionally adjusted for age, sex and 5 principal components.
cThe data set used to develop the PRS. There were 2929 cases and 3416 controls for cardiomegaly.
dCases (n = 2,624) and controls (n = 16,682) for the cardiomegaly phenotype that were not part of the derivation set.
eCases (n = 5,982) and controls (n = 21,198) for the cardiomegaly phenotype that were not part of the derivation set.